Harnessing the power of RNA interference to advance anticancer drug development.
Mousses
Spyro
S
Cancer Drug Development Laboratory, Translational Genomics Research Institute, Gaithersburg, Maryland 20878, USA. smousses@tgen.org
D004268:DNA-Binding Proteins; D015195:Drug Design; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009369:Neoplasms / Q000201:enzymology / Q000235:genetics* / Q000628:therapy*; D012313:RNA / Q000235:genetics*; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000235:genetics*; D019098:Telomerase / Q000235:genetics*; D016615:Telomere / Q000235:genetics
D004268:DNA-Binding Proteins; D034741:RNA, Small Interfering; C422952:telomerase RNA; D012313:RNA; D019098:Telomerase